Moderate riskFDA DrugClass II

Pro Numb Tattoo Numbing Spray recalled for cGMP deviations

Pro Numb Tattoo Numbing Spray (5% lidocaine) is being recalled due to manufacturing quality control issues. The FDA found that the product was not made under proper conditions. Certain lot numbers (J01–J14 and J55–J69) distributed nationwide may be affected.

From the FDA notice · Read the official notice ↗

What to do

  1. Check your bottle for lot number J01–J14 or J55–J69
  2. Stop using the product if you have an affected lot
  3. Dispose of the spray safely
  4. Contact Pro Numb Tattoo Numbing Spray LLC with questions about your specific bottle

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Pro Numb Tattoo Numbing Spray, 5% Lidocaine, [1 FL OZ/28.4 ML or 4 oz/120 mL] per bottle, Distributed by: Pro Numb Tattoo numbing spray LLC, Melbourne, FL 32907, NDC 83389-111-11
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 2 products — see all of them.

Details

Units affected
N/A
Illnesses reported
None reported
Manufactured in
3778 Dixie Hwy Ne Ste C, N/A, Palm Bay, FL, United States
Classification
Class II
Recall number
D-0302-2026

In the FDA's words

Description
Pro Numb Tattoo Numbing Spray, 5% Lidocaine, [1 FL OZ/28.4 ML or 4 oz/120 mL] per bottle, Distributed by: Pro Numb Tattoo numbing spray LLC, Melbourne, FL 32907, NDC 83389-111-11 cGMP deviations Lot Numbers J01 through J14, J55 through J69 Distribution: Nationwide in the USA Affected quantity: N/A
Hazard
cGMP deviations

2 products in this recall

Pro Numb tattoo numbing sprays recalled for manufacturing quality issues

Pro Numb is recalling two tattoo numbing sprays because they were made in ways that did not meet FDA manufacturing standards. The recall covers Pro Numb Tattoo Numbing Spray 5% Lidocaine and Pro Numb Tattoo Numbing Spray For Sensitive Skin 4% Lidocaine, sold nationwide in the USA. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

OtherDrugsSold nationwideMore from FDA Drug